A Prospective Observational Study of the Efficacy and Safety of CPT-11 Plus Platinum Analogues Regimens for UGT1A1 Genotype Guided Patients With Several Solid Tumors.

Trial Profile

A Prospective Observational Study of the Efficacy and Safety of CPT-11 Plus Platinum Analogues Regimens for UGT1A1 Genotype Guided Patients With Several Solid Tumors.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 31 May 2016

At a glance

  • Drugs Irinotecan (Primary) ; Carboplatin; Cisplatin; Nedaplatin
  • Indications Cervical cancer; Gastric cancer; Non-small cell lung cancer; Ovarian cancer; Small cell lung cancer
  • Focus Adverse reactions; Pharmacogenomic
  • Sponsors Daiichi Sankyo Inc
  • Most Recent Events

    • 28 Mar 2013 Planned End Date changed from 1 Mar 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.
    • 28 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 08 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top